ADVANCED HBV-RELATED HEPATOCELLULAR CARCINOMA

Clinical trials for ADVANCED HBV-RELATED HEPATOCELLULAR CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED HBV-RELATED HEPATOCELLULAR CARCINOMA trials appear

Sign up with your email to follow new studies for ADVANCED HBV-RELATED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for advanced liver cancer: Triple-Drug combo enters early testing

Disease control Not yet recruiting

This early-phase study tests a new drug (BRII-5395) combined with two approved cancer drugs (sintilimab and bevacizumab) in 21 adults with advanced liver cancer caused by hepatitis B. The main goal is to check safety and find the right dose, while also looking for signs that the …

Matched conditions: ADVANCED HBV-RELATED HEPATOCELLULAR CARCINOMA

Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated May 07, 2026 18:38 UTC

ADVANCED HBV-RELATED HEPATOCELLULAR CARCINOMA

Get alerted when new ADVANCED HBV-RELATED HEPATOCELLULAR CARCINOMA trials appear

New hope for advanced liver cancer: Triple-Drug combo enters early testing